Utility of contrast-enhanced harmonic endoscopic ultrasonography for diagnosis of liver metastases of the pancreatic carcinomas: a prospective cohort study

Utility of contrast-enhanced harmonic endoscopic ultrasonography for diagnosis of liver metastases of the pancreatic carcinomas: a prospective cohort study - Utility of contrast-enhanced harmonic endoscopic ultrasonography for diagnosis of liver metastases of the pancreatic carcinomas: a prospective cohort study

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000015096

Enrollment

200

Registered

2014-09-10

Start date

2014-09-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic carcinomas

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Pancreatic carcinoma with confirmation by imaging and pathological examinations. Written informed consent ECOG performance status = 0-2

Exclusion criteria

Exclusion criteria: Inapropriate to perform endoscopic ultrasonography Failure of other organs (ASA: Grade 3, 4) Inability to obtain informed consent

Design outcomes

Primary

Measure	Time frame
To calculate ability of contrast-enhanced harmonic EUS in diagnosing liver metastases from pancreatic carcinomas. To compare the ability of contrast-enhanced harmonic EUS in diagnosing liver metastases from pancreatic carcinomas with that of conventinal EUS.	—

Secondary

Measure	Time frame
To compare the ability of contrast-enhanced harmonic EUS with those of MDCT, MRI and PET.	—

Countries

Japan

Contacts

Public ContactMasayuki Kitano

Kinki University Faculty of Medicine Department of Gastroenterology and Hepatology

m-kitano@med.kindai.ac.jp072-366-0221

Outcome results